Venus Remedies has launched its R&D drug Elores, which is effective against multiple drug-resistant Gram-negative bacteria and has been patented in 46 countries including Japan and the US, in Oman's $7.5m antimicrobial market. Elores is aiming to capture 0.5% of the segment by 2025.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Ltkgbd6
via IFTTT
0 comments:
Post a Comment